Home / Medical Equipments / Global Personal Mobility Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017 To 2025

Global Personal Mobility Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017 To 2025

Published: Feb 2015 | Published By: Acute Market Research

Personal Mobility Devices Market - Growth, Future Prospects, Competitive Analysis, and Forecast, 2017 - 2025 the personal mobility devices market was valued at USD 75,35.5 Mn in 2017, and is expected to reach USD 22,383.8 Mn by 2025, expanding at a CAGR of 7.4% from 2017 to 2025.

Market Insights

Personal mobility devices refers to any assistive device that facilitates individual human transportation. Although many such devices are used by people with disability or mobility restrictions, mobility aids can be employed generally. Increasing geriatric population and rising prevalence of target bone diseases such as arthritis and osteoporosis among the aged population are major factors driving the market growth during the forecast period. Moreover, innovations in the personal mobility devices and market penetration in the under developed countries would further fuel the personal mobility devices market during the forecast period. Based on the type of products, the personal mobility devices market is categorized into wheelchairs, scooters, walking aids, patient lifts and stair lifts. The wheelchairs segment accounted for the largest share in the global personal mobility devices market. The key factors assisting the overall market growth of wheelchairs segment are high usage rates and growing demand for powered wheel chairs and its rising implementation in home use, hospitals, airports, hotels and other public places. However, walking aids segment it is anticipated to achieve significant growth in the near future due to the growing popularity of three and four wheeled rollators.

In the base 2015, North America formed the largest market for personal mobility devices market. The factors driving the North America personal mobility devices market are presence of supportive government and reimbursement schemes, developed healthcare infrastructure and growing geriatric population in the region are the factors driving North America personal mobility devices market. Asia Pacific is expected to register the fastest growth rate during the forecast period. Large presence of untapped opportunities in the emerging markets of India and China and constantly improving healthcare infrastructure in these markets are some attributes accounting for the aforementioned conclusion. Moreover, growing geriatric population in China and Japan and increasing disposable incomes, rising awareness and healthcare expenditure levels and the presence of government initiatives aimed at improving healthcare access in the region are few also expected to fuel the market during the forecast period.

Market Competition Assessment:

The personal mobility devices market is observed as the competitive market comprising large number of local players. The market is dominated by several players, depending on their major competencies. The key players in this market are Briggs Healthcare, Drive Medical Design & Manufacturing, Sunrise Medical, Electric Mobility, Patterson Medical, Pride mobility, Kaye Products, Nova, Eurovema AB, Graham-Field Health Products Incorporation, Invacare and TOPRO.

Key Market Movements:

• Growing geriatric population resulting in the rising in the bone diseases such as osteoporosis and arthritis
• Developing technologically advanced, compact and portable personal mobility devices
• Some major restrains for personal mobility devices market is the maintenance and purchasing cost

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Companion Diagnostics Market Portraiture
2.2 Companion Diagnostics Market, by Indication, 2015 (US$ Mn)
2.3 Companion Diagnostics Market, by Technology, 2015 (US$ Mn)
2.4 Companion Diagnostics Market, by Geography, 2015 (Value %)

Chapter 3 Global Companion Diagnostics Market Analysis
3.1 Global Companion Diagnostics Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increased Focus on Cost Cutting in Drug Discovery and Development
3.2.1.2 Increased Popularity of Personalized Medicines
3.2.1.3 Rapid Advancements in Science and Technology
3.2.1.4 Increase in Prevalence of Cancer and other Disorders
3.2.2 Challenges
3.2.2.1 High Cost Involved in Companion Diagnostics Development
3.2.2.2 Stringent Regulations
3.2.2.3 Need for Multidisciplinary Approach to Develop Efficient Companion Diagnostics
3.2.3 Opportunities
3.2.3.1 Increase in Number of Product Launches and Approvals
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Companion Diagnostics Market, 2015 (Value %)

Chapter 4 Global Companion Diagnostics Market, By Indications
4.1 Overview
4.2 Oncology
4.2.1 Breast Cancer
4.2.2 Colorectal Cancer
4.2.3 Gastric Cancer
4.2.4 Lung Cancer
4.2.5 Melanoma
4.2.6 Others
4.3 Cardiovascular Diseases
4.4 Infectious Diseases
4.5 Autoimmune Diseases

Chapter 5 Global Companion Diagnostics Market, By Technology
5.1 Overview
5.2 Polymerase Chain Reaction
5.3 Immunohistochemistry (IHC)
5.4 In-Situ Hybridization Test (ISH)
5.5 Gene Sequencing
5.6 Others

Chapter 6 Global Companion Diagnostics Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany, France, Spain, Italy & Rest of Europe)
6.4 Asia-Pacific
6.5 Latin America (Mexico, Brazil and Rest of LATAM)
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Abbott Laboratories, Inc.
7.2 Agilent Technologies, Inc.
7.3 bioMerieux SA
7.4 Qiagen N.V.
7.6 Roche Holdings AG
7.7 Thermo Fisher Scientific
7.7 Ventana Medical Systems
7.8 Myriad Genetics
7.9 Beckman Coulter

TABLE 1 Global Companion Diagnostics Market, By Indications (US$ Mn), 2015 - 2025 (Value)
TABLE 2 Global Companion Diagnostics Market for Oncology (US$ Mn), 2015 - 2025
TABLE 3 Global Companion Diagnostics Market, by Geography, 2015 - 2025 (USD Mn)
TABLE 4 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 5 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 6 bioMerieux SA: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 7 Qiagen N.V.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 8 Roche Holdings AG: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 9 Thermo Fisher Scientific: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 10 Ventana Medical Systems: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 11 Myriad Genetics: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 12 Beckman Coulter: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)

FIG. 1 Companion Diagnostics Market: Research Methodology
FIG. 2 Companion Diagnostics Market, by Indication, 2015 (US$ Mn)
FIG. 3 Companion Diagnostics Market, by Technology, 2015 (US$ Mn)
FIG. 4 Companion Diagnostics Market, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Companion Diagnostics Market, 2015 (Value %)
FIG. 7 Global Companion Diagnostics Market for Breast Cancer (US$ Mn), 2015 - 2025
FIG. 8 Global Companion Diagnostics Market for Colorectal Cancer (US$ Mn), 2015 - 2025
FIG. 9 Global Companion Diagnostics Market for Gastric Cancer (US$ Mn), 2015 - 2025
FIG. 10 Global Companion Diagnostics Market for Lung Cancer (US$ Mn), 2015 - 2025
FIG. 11 Global Companion Diagnostics Market for Melanoma (US$ Mn), 2015 - 2025
FIG. 12 Global Companion Diagnostics Market for Other Cancers (US$ Mn), 2015 - 2025
FIG. 13 Global Companion Diagnostics Market for Cardiovascular Diseases (US$ Mn), 2015 - 2025
FIG. 14 Global Companion Diagnostics Market for Infectious Diseases (US$ Mn), 2015 - 2025
FIG. 15 Global Companion Diagnostics Market for Autoimmune Diseases (US$ Mn), 2015 - 2025
FIG. 16 Global Polymerase Chain Reaction Market (US$ Mn), 2015 - 2025
FIG. 17 Global Immunohistochemistry Market (US$ Mn), 2015 - 2025
FIG. 18 Global In-Situ Hybridization Test Market (US$ Mn), 2015 - 2025
FIG. 19 Global Gene Sequencing Market (US$ Mn), 2015 - 2025
FIG. 20 Global Others Market (US$ Mn), 2015 - 2025
FIG. 21 North America Companion Diagnostics Market , by Country, 2015 - 2025 (USD Mn)
FIG. 22 Europe Companion Diagnostics Market, by Country, 2015 - 2025 (USD Mn)
FIG. 23 Asia-Pacific Companion Diagnostics Market, by Country, 2015 - 2025 (USD Mn)
FIG. 24 Latin America Companion Diagnostics Market, by Country, 2015 - 2025 (USD Mn)
FIG. 25 Middle East and Africa Companion Diagnostics Market , 2015 - 2025 (USD Mn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +